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The activation of KSHV lytic cycle blocks
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doxycycline; EBV, Epstein-Barr virus; EM, electron microscopy; KSHV, Kaposi’s sarcoma-associated herpesvirus; MAP1LC3/LC3,
microtubule-associated protein 1 light chain 3; PBS, phosphate-buffered saline; PEL, primary effusion lymphoma; RAB7, RAB7
member RAS oncogene family; SD, standard deviation; T/B, TPA/sodium butyrate; TPA, 2-O-tetradecanoylphorbol-13-acetate;
TUBA1A/a-tubulin, tubulin alpha 1a; VZV, varicella zoster virus.
This study confirms that autophagy is activated concomitantly with KSHV lytic cycle induction, and that autophagy
inhibition by BECN1 knockdown reduces viral lytic gene expression. In addition, we extend previous observations and
show that autophagy is blocked at late steps, during viral replication. This is indicated by the lack of colocalization of
autophagosomes and lysosomes and by the LC3-II level that does not increase in the presence of bafilomycin A1 in
primary effusion lymphoma (PEL) cells induced to enter the lytic cycle, either by TPA/sodium butyrate (BC3 and BCBL1)
or by doxycycline (TRExBCBL1-Rta). The autophagic block correlates with the downregulation of RAB7, whose silencing
with specific siRNA results in an autophagic block in the same cells. Finally, by electron microscopy analysis, we
observed viral particles inside autophagic vesicles in the cytoplasm of PEL cells undergoing viral replication, suggesting
that they may be involved in viral transport.
Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV) belongs to
the human gamma-herpesvirus subfamily, Rhadinoviridae
genus.1 It is associated with Kaposi’s sarcoma and some hemato-
logical malignancies, such as primary effusion lymphoma and
multicentric Castleman disease.2 KSHV infection of tumor cells
is mostly latent, but it can be switched into lytic cycle either in
vivo or in vitro upon appropriate stimuli such as exposure to 12-
O-tetradecanoylphorbol-13-acetate (TPA) alone or in combina-
tion with sodium butyrate (T/B),3-5 Bortezomib,6 ORF50
expression7 and doxycycline in TRExBCBL1-Rta cells.8 Upon
the activation of the lytic cycle, different sets of KSHV genes can
be expressed:9 immediate early (e.g., K-bZIP),10,11 early (e.g.,
ORF69)12 and late (e.g., K8.1).13 Autophagy is a process of self-
degradation of cellular components, upregulated in tumor cells
and in stressful conditions. This is a multistep process regulated
by the autophagy-related (ATG) genes.14 The vesicle nucleation,
that represents the first step of autophagy, is dependent on the
class III phosphatidylinositol 3-kinase complex formed by
PIK3C3/Vps34 (mammalian/yeast protein), PIK3R4/Vps15,
BECN1/Vps30/Atg6, and ATG14/Atg14. Among them
BECN1/Beclin 1, has a central role in this process, since it inter-
acts with molecules that regulate autophagy at several steps.15 A
marker of the autophagic vacuoles is MAP1LC3/LC3 (microtu-
bule-associated protein 1 light chain 3), an ortholog of yeast
Atg8, that is expressed as a full-length cytosolic protein and upon
autophagy induction is cleaved by ATG4 to form LC3-I, which
is then conjugated to phosphatidylethanolamine generating LC3-
II. In the last autophagic phases, autophagosomes, transporting
intracellular proteins, fuse with lysosomes. Autophagosomes can
also transport intracellular microorganisms to the lysosomes, con-
tributing to the clearance of the microbial infections.16 For that
reason viruses, especially those that persist in the infected host,
subvert autophagy to avoid their own elimination.17 However,
exceptions have been described and, for example, among herpes-
viruses, varicella zoster virus (VZV) is able to establish a success-
ful infection without affecting the autophagic process in the host
cells.18 In contrast, KSHV encodes several proteins that block
autophagy at multiple levels19-21 even if autophagy has been
shown to be activated and to promote the KSHV lytic cycle.22,23
In this study, besides confirming that autophagy is activated con-
comitantly with the KSHV lytic cycle in 2 different PEL cell sys-
tems and that autophagy promoted viral lytic gene expression, we
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found that the late autophagic steps were blocked, as indicated by
several lines of experimental evidence. Thus, the autophagic
block might represent a mechanism that allows KSHV to avoid
reaching the lysosomes and be degraded by the lysosomal pro-
teases. Meanwhile, this strategy enables KSHV to hijack the auto-
phagic machinery to travel toward the cell surface. Based on the
results obtained in this study, we suggest that autophagy manipu-
lation could be exploited to reduce viral replication and conse-
quently to improve the outcome of therapies against KSHV-
associated malignancies, whose pathogenesis correlates with con-
tinuous viral release.
Results and Discussion
BC3 and BCBL1 PEL cells were treated with TPA (20 ng/ml)
and sodium butyrate (0.3 mM) combined (T/B) for 36 h, to
induce the KSHV lytic cycle. We found that at this time, when
the KSHV lytic cycle was activated (as indicated by K-bZIP lytic
antigen expression), the level of the lipidated form of LC3 (LC3-
II) increased in comparison to the onset of viral replication (time
0) and to untreated controls (-) in both PEL cell lines (Fig. 1A).
Of note, in BCBL1 cells a certain amount of spontaneous viral
replication occurred (indicated by the low expression of K-bZIP
in the untreated cells) and concomitantly a higher basal level of
LC3-II was also detected. Then, BC3 and BCBL1 cells were
transfected with a pEGFP-LC3 plasmid and treated with T/B.24
We found that autophagosomes, revealed by GFP-LC3 puncta,
accumulated in PEL cells undergoing KSHV replication and
expressing K8.1 membrane antigen (Fig. 1B). The majority of
replicating cells (about 70%) showed GFP-LC3 puncta; con-
versely, only 10% of the cells not undergoing KSHV replication,
showed GFP-LC3 puncta (data not shown), suggesting that
autophagy was induced during KSHV lytic cycle activation. We
then stably transfected BC3 cells with a pEGFP-LC3 plasmid, to
avoid artifactual results14,25 and quantified the number of LC3-
positive BC3 cells, induced or not to enter the KSHV lytic cycle
by T/B for 0, 18, 36 and 60 h. The results shown in Fig. 1C
indicate that the number of GFP-LC3-positive cells (containing
at least 5 GFP-LC3 puncta)26 increased up to 36 h of T/B treat-
ment, whereas it was slightly changed in the untreated control
cells. Similar results were obtained with transiently pEGFP-LC3
plasmid-transfected BC3 cells (Fig. 1D). For these quantitative
experiments we counted about 200 cells induced or not to enter
the lytic cycle, for each time point. The accumulation of LC3-II
as well as of autophagosomes suggest the activation of the auto-
phagic process, but they do not make it possible to assess the
completeness of the autophagic flux, since both LC3-II and auto-
phagosomes are formed and degraded during autophagy
induction.14
To shed more light on this process, we added bafilomycin A1
(Baf; 20 nM) to PEL cells, during the last 3 h of T/B treatment.
Baf, as an inhibitor of the vacuolar-type H+-ATPase, prevents
LC3-II degradation and allows the evaluation of total LC3-II for-
mation. We found that the LC3-II level did not increase after
36 h of T/B treatment in combination with Baf (Fig. 2A), a time
at which the KSHV lytic cycle was induced (evidenced by the
expression of the KSHV lytic antigen K-bZIP), suggesting the
occurrence of an autophagic block during KSHV replication. In
contrast, a complete autophagic flux was observed in BJAB, a
KSHV-negative lymphoma cell line, undergoing 36 h of T/B
treatment (Fig. 2B). Concomitant with the lytic cycle activation
and the autophagic block, we found that expression of RAB7
(a member of the RAS oncogene family) was reduced in BC3
cells (Fig. 2A). RAB7,27 besides regulating lysosome biogene-
sis,28 plays an important role in the fusion of autophagosomes
with lysosomes, a step required for a complete autophagic flux.29
Next, a kinetic evaluation of the expression of K-bZIP, RAB7
and LC3-I/-II was performed after 0, 9, 18 and 36 h of T/B
treatment in the presence or in the absence of Baf. As shown in
Figure 2C, when the KSHV lytic cycle was induced, RAB7
expression was reduced and an autophagic block occurred, based
on the change in the level of LC3-II in the presence or in the
absence of Baf.
Then, to further analyze the autophagic flux, we investigated
the localization of autophagosomes and lysosomes and observed
that in the majority of PEL cells treated with T/B for 36 h, the
GFP-LC3 puncta (stained in green and indicating autophago-
somes) did not colocalize with the lysosomes (stained in red with
LysoTracker Red). Conversely, at earlier time points some of the
autophgosomes and lysosomes colocalized, as indicated by the
appearance of yellow puncta (Fig. 2D). These results are in
agreement with those obtained for LC3-II in the presence of Baf
by western blot analysis (Fig. 2C) and suggest that the autopha-
gic flux was complete during the first 18 h of T/B treatment,
whereas it was blocked when the KSHV lytic antigens start to be
expressed. Finally, by transfecting BC3 cells with the pDest-
mCherry-EGFP-LC3B plasmid,30 we found that in T/B-treated
cells most of the autophagic structures displayed yellow fluores-
cence, due to the concomitant expression of mCherry and GFP,
corresponding to autophagosomes. In contrast, the GFP compo-
nent of the fluorescence was decreased by the complete autopha-
gic flux induced by starvation in the same cells (due to instability
of GFP in the lysosome) and consequently most of the autopha-
gic structures appeared red, corresponding to autolysosomes
(Fig. 2E). These results further suggest that the KSHV lytic cycle
activation might impair the fusion between autophagosomes and
lysosomes in PEL cells.
We then investigated the completeness of the autophagic flux
in a different cell system, the TRExBCBL1-Rta cells. We
observed that an autophagic block occurred also in these cells
induced to enter the lytic cycle by doxycycline treatment for 48 h
while a complete autophagy was observed in TRExBCBL1-vector
control cells undergoing doxycycline treatment for the same time
(Fig. 3A). The efficiency of lytic cycle induction by doxycycline
in TRExBCBL1-Rta cells was analyzed in the same cells either by
western blot (Fig. 3B) or by immunofluorescence (Fig. 3C), to
further confirm that a block of the autophagic flux was occurring
concomitantly with KSHV lytic cycle activation. Upon lytic cycle
activation, we found that RAB7 was downregulated also in these
cells (Fig. 3B), suggesting that it could be one of the mechanisms
underlying the block of autophagy at the final steps during
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KSHV replication. Then, to demonstrate that the reduction of
RAB7 would lead to a block of autophagy in PEL cells, we
silenced this molecule by specific siRNA (Fig. 4A) and found
that indeed LC3-II did not further increase in the presence of Baf
in RAB7 knockdown cells (Fig. 4B). A reduction of RAB7
expression was also previously observed during the replication of
Epstein-Barr virus (EBV),17 another member of the gamma-her-
pesviruses subfamily, Lymphocryptoviridae genus, suggesting that
it represents a common feature during gamma-herpesvirus repli-
cation. Moreover, the results obtained in this study are in agree-
ment with a recent paper reporting that the transfection of the
KSHV K7 lytic protein impaired the fusion of autophagosomes
Figure 1. T/B activates autophagy concomitant with KSHV lytic cycle induction in PEL cells. (A) Western blot analysis showing the accumulation of the
lipidated form of LC3 (LC3-II) concomitant with the expression of K-bZIP lytic cycle antigen induced by TPA at 20 ng/ml and sodium butyrate at 0.3 mM
(T/B) upon 36 h of treatment in BC3 and BCBL1 cells, in comparison to the untreated control. LC3-I/-II as well as K-bZIP at the onset of the viral lytic cycle
are also shown. TUBA1A/a-tubulin was used as loading control and a representative experiment out of 3 is shown. The histograms represent the mean
plus standard deviation (SD) of the densitometric analysis of the ratio of K-bZIP or LC3-II to TUBA1A of 3 different experiments. (B) PEL cells were trans-
fected with pEGFP-LC3 plasmid before inducing the lytic cycle with T/B. Autophagy activation was revealed by the appearance of GFP-LC3 puncta
(green) and the cells undergoing KSHV lytic cycle were indicated by the expression of KSHV K8.1, a membrane lytic protein, by using a specific monoclo-
nal antibody (red staining). Bar: 5 micron. (C) BC3 cells were stably transfected with pEGFP-LC3 plasmid and quantification of cells expressing more than
5 GFP-LC3 puncta per cell (as evaluated by immune fluorescence microscopy) was performed in both unreactivated and T/B reactivated PEL cells at 4
time points: 0, 18, 36 and 60 h. (D) BC3 cells were transiently transfected with pEGFP-LC3 plasmid and quantification of cells expressing more than 5
GFP-LC3 puncta per cell (as evaluated by immune fluorescence microscopy) was performed in both unreactivated and T/B reactivated PEL cells at 4 time
points: 0, 18, 36 and 60 h. About 200 cells were counted for each time point.
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Figure 2. The autophagic flux was blocked in BC3 cells undergoing KSHV lytic cycle activation. (A) Analysis of K-bZIP lytic antigen, RAB7 and LC3-I/-II
expression in the presence or in the absence of Baf (used for the last 3 h at 20 nM) in BC3 cells induced to enter the lytic cycle by T/B treatment for 36 h
or (B) in the KSHV-negative BJAB cells undergoing the same treatment. (C) Kinetic analysis of the expression of K-bZIP, RAB7 and LC3-II and effects of Baf
on the expression of K-bZIP, RAB7 and LC3-II in BC3 cells induced to enter the lytic cycle by T/B at the indicated time points. ACTB was used as loading
control and a representative experiment out of 3 is shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of spe-
cific proteins to ACTB of 3 different experiments. (D) BC3 cells were transfected with pEGFP-LC3 plasmid and induced to enter the lytic cycle by T/B treat-
ment for 0, 18 and 36 h. Lysosomes were stained in red with LysoTracker while autophagosomes were indicated by GFP-LC3 puncta. Bar: 5 micron. (E)
Gallery of BC3 cells transfected with pDest-mCherry-EGFP-LC3B plasmid and treated with T/B for 36 h or starved for 2 h. The yellow puncta indicate auto-
phagosomes while red puncta indicate autolysosomes. A representative experiment out of 3 is shown. Bar: 5 micron.
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with lysosomes in HeLa cells, in which autophagy was induced
by rapamycin. 31
Next, to investigate the role of autophagy in the KSHV lytic
cycle, we knocked down BECN1, a gene essential for the auto-
phagic process, before inducing the lytic cycle with T/B. We
found that KSHV K-bZIP lytic protein expression was reduced
in BECN1-silenced BC3 cells in comparison to the scramble con-
trol (Fig. 5A). Accordingly, the number of cells expressing K-
bZIP was strongly reduced by BECN1 knockdown (Fig. 5B).
Similar results were obtained by ATG5 silencing (data not
shown). These results indicate that autophagy promoted the
KSHV lytic cycle, in agreement with a recent study22 and simi-
larly to what we and other authors have previously observed dur-
ing EBV replication.17,32-34 Finally, by electron microscopy
(EM) analysis, autophagic features were observed in the majority
of virus-producing cells and about 30% of viral particles were
Figure 3. The autophagic flux was blocked in TRExBCBL1-Rta cells undergoing KSHV lytic cycle activation by doxycycline treatment. (A) Evaluation of the
autophagic flux based on LC3-II accumulation in the presence or in the absence of Baf (used for the last 3 h at 20 nM) in TRExBCBL1-Rta cells induced to
enter the lytic cycle by treatment with doxycycline for 48 h. TRExBCBL1-vector cells were used as control. (B) The expression of KSHV lytic antigen K8.1
and RAB7 was analyzed by western blot. TUBA1A was used as loading control and a representative experiment out of 3 is shown. The histograms repre-
sent the mean plus SD of the densitometric analysis of the ratio of LC3-II, K8.1 or RAB7 to TUBA1A of 3 different experiments. (C) Percentage of cells
expressing K8.1 (red) lytic antigen analyzed by immunofluorescence. Nuclei were stained by DAPI (blue).
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contained within the double-membrane autophagic vesicles pres-
ent in the cytoplasm of PEL cells induced to enter the KSHV
lytic cycle (200 cells were analyzed; Fig. 5C). Based on this
observation and on the negative effect of autophagy inhibition
on viral lytic expression, we propose that KSHV, similarly to
EBV, might exploit the autophagic machinery for its transport,
to enhance viral production. The study of the mechanisms that
regulate KSHV lytic cycle activation are of fundamental impor-
tance since KSHV-associated malignancies, such as Kaposi’s sar-
coma, are characterized by a continuous release of viral particles
that contributes to the disease’s maintenance.35 The finding that
autophagy is involved in KSHV replication suggests that manip-
ulation of this process could lead to a better control of viral pro-
duction and could restrain the progression of KSHV-associated
malignancy diseases.
Materials and Methods
Cell culture and reagents
BC3 (ATCC, CRL-2277), BCBL1 (kindly provided by Prof. P.
Monini, National AIDS Center, Istituto Superiore di Sanita,
Rome, Italy), TRExBCBL1-Rta (kindly provided by Prof. J. Jung,
Dept. of Molecular Microbiology and Immunology, University of
Southern California, Keck School of Medicine, Los Angeles,
California, USA) and TRExBCBL1-
vector (kindly provided by Prof. J.
Jung, Dept. of Molecular Microbiol-
ogy and Immunology, University of
Southern California, Keck School of
Medicine, Los Angeles, California,
USA)8 are human B-cell lines derived
from PEL-carrying latent KSHV.
BJAB is an EBV-negative Burkitt
lymphoma cell line (kindly provided
by Prof. MG Masucci, Department
of Cell and Molecular Biology,
Karolinska Institutet, Stockholm),
Sweden). The cells were cultured
in RPMI 1640 (Sigma, R0883),
10% fetal calf serum (Euroclone,
ECLS0180L), L-glutamine and strep-
tomycin (100 mg/ml) and penicillin
(100 U/ml) (Gibco, 10378-016) in
5% CO2 at 37
C. TRExBCBL1-Rta
and TRExBCBL1-vector cell lines
(kindly provided by Prof. J. Jung)
were cultured using the samemedium
in the presence of hygromycin (100
mg/ml) (Sigma Aldrich, H0654) and
blasticidin (100 mg/ml; Santa Cruz
Biotechnology, sc-204655A) in 5%
CO2 at 37
C. The KSHV lytic cycle
was induced in BC3 and BCBL1 cells
by treatment with TPA (20 ng/ml;
Sigma Aldrich, P8139) and sodium
butyrate (0.3 mM; Sigma Aldrich, B5887) for the indicated times.
Otherwise, the viral replication in TRExBCBL1-Rta cells was acti-
vated by treatment with doxycycline (1mg/ml) (Sigma, D1822) for
the indicated times. To investigate autophagy, the cells were treated
with Baf (20 nM; Santa Cruz Biotechnology, sc-201550) for the
last 3 h.25
A stable BC3 cell line expressing GFP-LC3 was grown in
complete RPMI medium supplemented with 0.8 mg/ml geneti-
cin/G418 (Life Technologies, 10131-027)
Antibodies
In western blotting analysis, we used in this work the follow-
ing primary antibodies: mouse monoclonal anti-K-bZIP (1:500;
Santa Cruz Biotechnology, sc-69797), mouse monoclonal anti-
K8.1 (1:400; ABI Advanced Biotechnologies, 13-213-100) and
rabbit polyclonal anti-RAB7 (1:500; Santa Cruz Biotechnology,
sc-10767). To study autophagy we used the following primary
antibodies: rabbit polyclonal anti-LC3 (1:1000; Novus Biologi-
cals, NB100-2220SS) and rabbit polyclonal anti-BECN1
(1:1000; Cell Signaling Technology, 3738S).
Monoclonal mouse anti-TUBA1A/a-tubulin (1:1000; Sigma
Aldrich, T6199), anti-ACTB/b¡actin (1:10000; Sigma Aldrich,
A5441) and anti-GAPDH (Santa Cruz Biotechnology, sc-
13717) were used as loading controls. The goat polyclonal
anti-mouse IgG-HRP (Santa Cruz Biotechnology, sc-2005) and
Figure 4. RAB7 knockdown leads to an autophagic block in PEL cells. BCBL1 cells were knocked down for
RAB7 or scramble (SC) treated and (A) RAB7 and (B) LC3-II expression level was evaluated in the presence
or in the absence of Baf. TUBA1A was used as loading control and a representative experiment out of 3 is
shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of LC3-II to
TUBA1A of 3 different experiments.
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anti-rabbit IgG-HRP (Santa
Cruz Biotechnology, sc-2004)
were used as secondary antibod-
ies. All the primary and second-
ary antibodies were diluted in
phosphate-buffered saline (PBS;
Sigma Aldrich, D8537) -0.1%
Tween 20 (Sigma Aldrich,
P1379) solution containing 3%
BSA (Serva, 11943.03)
Western blot analyses
1 £ 106 cells were washed
twice with 1X PBS-0.1% Tween
20 solution and centrifuged at
212 x g for 5 min. The pellet frac-
tion was lysed in a RIPA buffer
containing 150 mM NaCl, 1%
NP-40 (Sigma Aldrich, NP40S),
50 mM Tris-HCl, pH 8, 0.5%
deoxycholic acid (Sigma Aldrich,
D6750), 0.1% SDS (Sigma
Aldrich,71736), protease (Sigma
Aldrich, S8830) and phosphatase
inhibitors (Sodium Orthovana-
date; Sigma Aldrich, S6508)
(Sodium Fluoride; Sigma Aldrich,
S7920). Then, 30 mg of protein
lysates were subjected to electro-
phoresis on 4-12% NuPage Bis-
Tris gels (Life Technologies,
N00322BOX) according to the
manufacturer’s instruction. To
evaluate the LC3-I/-II, the cell
lysates were denatured in 3X
Loading Protein Buffer (150 mM
Tris-HCl, pH 6.8, 6% SDS, 30% glycerol, 30 mM EDTA, 0.2%
Bromophenol Blue) for 5 min at 100C and run on a 15% gel
(30% acrylamide/Bis Solution 29:1; Bio-Rad, 161-0159) in Tris-
glycine-SDS buffer (Bio-Rad, 1610772). Then, the gels were
transferred to nitrocellulose membranes (Bio-Rad, 162-0115) for
2 h in Tris-glycine buffer. The membranes were blocked in PBS-
0.1% Tween 20 solution containing 3% BSA, probed with spe-
cific antibodies and developed using ECL Blotting Substrate
(Advansta, K-12045-D20).
Electron microscopy analysis
PEL cells were treated with TPA (20 ng/ml) and sodium
butyrate (0.3 mM) at the indicated times. Subsequently, cells
were fixed in 2% glutaraldehyde (Electron Microscopy Sciences,
111-30-8) in 1X PBS for 24 h at 4C, post-fixed in 1% OsO4
(Agar Scientific, R1016) for 2 h and stained for 1 h in 1% aque-
ous uranyl-acetate (Electron Microscopy Sciences, 22400). The
samples were then dehydrated with graded acetone and embed-
ded in Epon-812 (Electron Microscopy Sciences, 14120). One-
micron thick sections were cut, stained with 1% methylene blue
and viewed by light microscopy to select representative areas.
Ultrathin sections were cut with a Reichert ultramicrotome,
counterstained with uranyl acetate and lead citrate, and examined
with a Philips CM10 transmission electron microscope (FEI).
Knockdown by small interfering RNA
The knockdown of BECN1 (Santa Cruz Biotechnology, sc-
29797) or RAB7 (Santa Cruz Biotechnology, sc-29460) was per-
formed in PEL cell lines using specific small interfering RNA
duplex. The day before transfection, 3 £ 105 cells were seeded in
12-well culture plates in RPMI medium without antibiotics.
Subsequently, 75 pmol of siRNA duplex and 7.5 ml of Lipofect-
amine 2000 Transfection Reagent (Life Technologies,
11668027) were diluted in Optimem medium (Life Technolo-
gies, 31985062) and added to the cells for 48 h. The transfection
efficiency was evaluated by a Fluorescein Conjugate-A siRNA
(Santa Cruz Biotechnology, sc-36869), which was also used as a
scrambled control.
Figure 5. Autophagy enhances the KSHV lytic cycle. (A) K-bZIP expression was evaluated by western blot
analysis in BC3 cells transfected with scramble (SC) or BECN1 siRNA for 48 h and then induced to enter the
lytic cycle by 36 h of T/B treatment. GAPDH was used as a loading control and a representative experiment
out of 3 is shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of
BECN1 or K-bZIP to GAPDH of 3 different experiments. (B) BC3 cells transfected with scramble (SC) or BECN1
siRNA for 48 h and then induced to enter the lytic cycle by 36 h of T/B were analyzed for K-bZIP (red) expres-
sion by immunofluorescence. Nuclei were stained by DAPI (blue). The histograms represent the mean plus SD
of the percentage of K-bZIP-positive cells of 3 different experiments. (C) Electron microscopy analysis of BC3
cells induced to enter the lytic cycle by T/B. Autophagic vacuoles containing viral particles (arrows) were
observed in the cytoplasm of BC3 virus-producing cells. Au, autophagosomes; er, endoplasmic reticulum; G,
Golgi apparatus; M, mitochondrion; N, nucleus. Bar: 0.5 mm.
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Transfection and plasmids
We performed a transient transfection using the pEGFP-LC3
plasmid (kindly provided by Prof. G.M. Fimia, National Insti-
tute for Infectious Disease ‘L. Spallanzani’ IRCCS, Rome,
Italy)24 or pDest-mCherry-EGFP-LC3B plasmid (kindly pro-
vided by Prof. T. Johansen, Molecular Cancer Research Group,
Institute of Medical Biology, University of Tromsø and The Arc-
tic University of Norway, Tromsø, Norway)30 in PEL cell lines.
5 £ 105 cells were seeded into 6-well plates and then transfected
with 5 mg of plasmid DNA/well with Lipofectamine 2000
according to the manufacturer’s instructions. After 48 h, the cells
were treated with TPA (20 ng/ml) and sodium butyrate (3 mM)
for the indicated times. In order to activate autophagy, BC3 cells
were transfected with pDest-mCherry-EGFP-LC3B for 48 h and
then were cultured in Hank’s balanced salt solution (Sigma
Aldrich, E6267) medium for 3 h. The pDest-mCherry-EGFP-
LC3B plasmid makes it possible to visualize the autophagic steps
because the LC3 puncta, indicating autophagosomes arising dur-
ing autophagy induction, change their color depending on the
pH; they appear yellow when both green and red colors are
expressed, but when autophagosomes fuse with lysosomes the
GFP is unstable and autolysosomes become red. The LC3 dots
were visualized with an Apotome Axio Observer Z1 inverted
microscope (Zeiss, Germany) equipped with an AxioCam MRM
(Zeiss, Germany) Rev.3 at 40 £ magnification.
We generated a stably transfected BC3 cells with a plasmid
expressing GFP-LC3. Briefly, 5 £ 105 BC3 cells were cultured
into 6-well plates and transfected with 5 mg of pEGFP-LC3 plas-
mid/well with Lipofectamine 2000 according to the man-
ufacturer’s instructions. After 48 h, the cells were resuspended in
a medium containing 1.5 mg/ml of G418 and seeded in 96-well
plates. After 10-14 d, the GFP-LC3-positive clones were isolated
and selected by fluorescence microscopy.
Immunofluorescence
KSHV replication was activated with the lytic cycle inducers
in PEL cell lines, as previously described. The cells were har-
vested, washed twice in 1X PBS and then incubated with mouse
monoclonal anti-K8.1 antibody (1:300 in PBS; ABI Advanced
Biotechnologies, 13-213-100) for 1 h on ice. Subsequently, they
were washed 3 times in cold 1X PBS and incubated with poly-
clonal Cy3-conjugated sheep-anti mouse (1:100 in 1X PBS; Jack-
son Immunoresearch Laboratories, 515-165-062) for 30 min on
ice. Finally, after several washing, the cells were resuspended in a
1X PBS-glycerol solution (1:1).
After BECN1 silencing, KSHV replication was induced by
TPA (20 ng/ml) and sodium butyrate (0.3 mM) at the indicated
times in BC3 cells. Cells were then harvested, washed twice in
PBS, seeded on glass slides, air dried and permeabilized/fixed in
acetone-methanol (1:1) for 10 min. The slides were then incu-
bated with mouse monoclonal anti-K-bZIP antibody for 1 h.
They were washed 3 times in 1X PBS and incubated with poly-
clonal Cy3-conjugated sheep-anti mouse for 30 min. Finally,
after several washings, cells were incubated with 4,6-diamidino-
2-phenylindole (DAPI) to visualize the nuclei and the coverslips
were mounted face down using a PBS-glycerol (1:1) solution.
The immunofluorescence was analyzed using an Apotome Axio
Observer Z1 inverted microscope, equipped with an AxioCam
MRM Rev.3 at 40 £ magnification.
LysoTracker Red staining
BC3 cells transfected with pEGFP-LC3 were treated with
TPA (20 ng/ml) and sodium butyrate (0.3 mM) for the indi-
cated times, washed in PBS solution, and incubated with Lyso-
Tracker Red DND-99 (100 nM; Life Technologies, L7528), a
fluorescent acidotropic probe with high selectivity for acidic
organelles, for 30 min at room temperature.35 After several wash-
ings with PBS solution, the lysosomes were analyzed using an
Apotome Axio Observer Z1 inverted microscope equipped with
an AxioCam MRM Rev.3 at x40 magnification.
Densitometric analysis
The quantification of proteins bands was performed by densi-
tometric analysis using the ImageJ software, which was down-
loaded from the NIH web site (http://imagej.nih.gov).
Statistical analysis
All data are represented by the mean § standard error of at
least 3 independent experiments.
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